GlassScriptPhysician profile
Jordan W Young
NPI 1508224775
$11,613.03
in general payments reported to CMS, 2019-2025
52 companies · $4,257 in 2025
The $4,257 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $975 · 2022: $1,388 · 2023: $1,741 · 2024: $3,252 · 2025: $4,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,075 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,075.31 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,900.97 | 2021-2025 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Abbvie INC. | $1,002.31 | 2021-2025 | |
| Pfizer INC. | $829.25 | 2021-2025 | |
| Sk Life Science, INC. | $803.40 | 2023-2025 | Xcopri |
| Novartis Pharmaceuticals Corporation | $492.56 | 2023-2025 | |
| Argenx US, INC. | $461.73 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $454.19 | 2023-2025 | Rystiggo, Nayzilam, Briviact |
| Acadia Pharmaceuticals INC | $452.73 | 2023-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $402.88 | 2023-2025 | Ultomiris, Soliris, Koselugo |
| Teva Pharmaceuticals USA, INC. | $336.49 | 2021-2025 | Austedo Xr, Austedo Xr |
| Merz Pharmaceuticals, LLC | $307.58 | 2021-2025 | Xeomin, Inbrija |
| Biogen, INC. | $300.16 | 2023-2025 | Vumerity, Skyclarys, Tysabri |
| Lilly USA, LLC | $294.93 | 2021-2025 | Kisunla, Reyvow, Emgality |
| Harmony Biosciences LLC | $279.64 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $276.67 | 2023-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $235.14 | 2023-2025 | Vyepti, Rexulti |
| Livanova USA, INC. | $226.58 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Collegium Pharmaceutical, INC. | $223.10 | 2021-2023 | Belbuca |
| Neurelis, INC. | $208.00 | 2024-2025 | Valtoco |
| Amgen INC. | $180.73 | 2021-2025 | Uplizna |
| Genentech USA, INC. | $178.72 | 2023-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Otsuka America Pharmaceutical, INC. | $173.54 | 2024-2025 | Rexulti, Nuedexta |
| Emd Serono, INC. | $149.88 | 2024-2025 | |
| Si-Bone, INC. | $125.13 | 2021-2022 | |
| Relievant Medsystems, INC. | $113.40 | 2021-2023 | Intracept |
| Catalyst Pharmaceuticals, INC. | $100.16 | 2024 | |
| Tanabe Pharma America, INC. | $98.71 | 2024 | |
| Eisai INC. | $91.99 | 2021-2025 | |
| Tg Therapeutics, INC. | $88.71 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $73.96 | 2024-2025 | Ingrezza |
| Depuy Synthes Sales INC. | $73.63 | 2021-2023 | Monovisc |
| Alnylam Pharmaceuticals INC. | $58.27 | 2023-2024 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $57.04 | 2024-2025 | Wainua |
| Biohaven Pharmaceuticals, INC. | $52.54 | 2021 | |
| Amneal Pharmaceuticals LLC | $52.41 | 2023-2025 | Rytary, Ongentys, Crexont |
| Springworks Therapeutics, INC. | $50.48 | 2025 | Gomekli |
| Biodelivery Sciences International, INC. | $45.24 | 2021 | |
| Genzyme Corporation | $44.03 | 2023-2024 | |
| Ani Pharmaceuticals, INC. | $41.71 | 2025 | Purified Cortrophin Gel |
| Abbott Laboratories | $37.84 | 2021-2023 | Quantisal |
| Takeda Pharmaceuticals U.S.A., INC. | $32.06 | 2025 | Hyqvia |
| Averitas Pharma INC. | $26.37 | 2023 | Qutenza |
| Boston Scientific Corporation | $22.01 | 2025 | General - Pain Management |
| Axsome Therapeutics, INC. | $21.73 | 2025 | Symbravo |
| Piramal Critical Care | $19.50 | 2025 | |
| Avanos Medical | $17.97 | 2022 | |
| Impel Pharmaceuticals INC. | $17.76 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.11 | 2022 | |
| Cala Health, INC. | $16.80 | 2025 | Cala Kiq |
| Sumitomo Pharma America, INC. | $16.53 | 2023 | Aptiom |
| Currax Pharmaceuticals LLC | $15.13 | 2021 | |
| Horizon Therapeutics Plc | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.